Gene Signature For Predicting Prognosis Of Patients With Solid Tumors


Ontology type: sgo:Patent     


Patent Info

DATE

2014-08-07T00:00

AUTHORS

Xin Wei Wang , Stephanie K. Roessler

ABSTRACT

Disclosed herein is a driver gene signature for predicting survival in patients with solid tumors, such as hepatocellular carcinoma (HCC) and breast cancer. The gene signature includes ten tumor-associated genes, SH2D4A, CCDC25, ELP3, DLC1, PROSC, SORBS3, HNRPD, PAQR3, PHF17 and DCK. A decrease in DNA copy number or mRNA expression of SH2D4A, CCDC25, ELP3, DLC1, PROSC and SORBS3 in solid tumors is associated with a poor prognosis, while a decrease in DNA copy number or mRNA expression of HNRPD, PAQR3, PHF17 and DCK in solid tumors is associated with a good prognosis. Methods of predicting the prognosis of a patient diagnosed with HCC or breast cancer by detecting expression of one of more tumor-associated genes, and methods of treating a patient diagnosed with HCC or breast cancer by administering an agent that alters expression or activity of one or more of the disclosed tumor-associated genes, are described. More... »

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2620", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Xin Wei Wang", 
        "type": "Person"
      }, 
      {
        "name": "Stephanie K. Roessler", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1159/000072654", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012895947"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.gt.3301923", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043735865", 
          "https://doi.org/10.1038/sj.gt.3301923"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.gt.3301923", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043735865", 
          "https://doi.org/10.1038/sj.gt.3301923"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-08-07T00:00", 
    "description": "

Disclosed herein is a driver gene signature for predicting survival in patients with solid tumors, such as hepatocellular carcinoma (HCC) and breast cancer. The gene signature includes ten tumor-associated genes, SH2D4A, CCDC25, ELP3, DLC1, PROSC, SORBS3, HNRPD, PAQR3, PHF17 and DCK. A decrease in DNA copy number or mRNA expression of SH2D4A, CCDC25, ELP3, DLC1, PROSC and SORBS3 in solid tumors is associated with a poor prognosis, while a decrease in DNA copy number or mRNA expression of HNRPD, PAQR3, PHF17 and DCK in solid tumors is associated with a good prognosis. Methods of predicting the prognosis of a patient diagnosed with HCC or breast cancer by detecting expression of one of more tumor-associated genes, and methods of treating a patient diagnosed with HCC or breast cancer by administering an agent that alters expression or activity of one or more of the disclosed tumor-associated genes, are described.

", "id": "sg:patent.US-20140220043-A1", "keywords": [ "gene signature", "survival", "patient", "solid tumor", "hepatocellular carcinoma", "Breast Neoplasm", "associated gene", "DLC1", "decrease", "DNA copy number", "mRNA expression", "poor prognosis", "good prognosis", "Predicting", "prognosis", "expression", "method", "agent" ], "name": "GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.27235.31", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-20140220043-A1" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:13", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_00817.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-20140220043-A1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-20140220043-A1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-20140220043-A1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-20140220043-A1'


 

This table displays all metadata directly associated to this object as RDF triples.

54 TRIPLES      15 PREDICATES      35 URIs      26 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-20140220043-A1 schema:about anzsrc-for:2620
2 anzsrc-for:3142
3 schema:author N810f045928974e91ae1734ff17ed17cc
4 schema:citation sg:pub.10.1038/sj.gt.3301923
5 https://doi.org/10.1159/000072654
6 schema:datePublished 2014-08-07T00:00
7 schema:description <p id="p-0001" num="0000">Disclosed herein is a driver gene signature for predicting survival in patients with solid tumors, such as hepatocellular carcinoma (HCC) and breast cancer. The gene signature includes ten tumor-associated genes, SH2D4A, CCDC25, ELP3, DLC1, PROSC, SORBS3, HNRPD, PAQR3, PHF17 and DCK. A decrease in DNA copy number or mRNA expression of SH2D4A, CCDC25, ELP3, DLC1, PROSC and SORBS3 in solid tumors is associated with a poor prognosis, while a decrease in DNA copy number or mRNA expression of HNRPD, PAQR3, PHF17 and DCK in solid tumors is associated with a good prognosis. Methods of predicting the prognosis of a patient diagnosed with HCC or breast cancer by detecting expression of one of more tumor-associated genes, and methods of treating a patient diagnosed with HCC or breast cancer by administering an agent that alters expression or activity of one or more of the disclosed tumor-associated genes, are described.</p>
8 schema:keywords Breast Neoplasm
9 DLC1
10 DNA copy number
11 Predicting
12 agent
13 associated gene
14 decrease
15 expression
16 gene signature
17 good prognosis
18 hepatocellular carcinoma
19 mRNA expression
20 method
21 patient
22 poor prognosis
23 prognosis
24 solid tumor
25 survival
26 schema:name GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS
27 schema:recipient https://www.grid.ac/institutes/grid.27235.31
28 schema:sameAs https://app.dimensions.ai/details/patent/US-20140220043-A1
29 schema:sdDatePublished 2019-04-18T10:13
30 schema:sdLicense https://scigraph.springernature.com/explorer/license/
31 schema:sdPublisher N4cba51456c37466090388dd5c75894e0
32 sgo:license sg:explorer/license/
33 sgo:sdDataset patents
34 rdf:type sgo:Patent
35 N4cba51456c37466090388dd5c75894e0 schema:name Springer Nature - SN SciGraph project
36 rdf:type schema:Organization
37 N52b53f27513644a7a5c0e7aef416eee5 rdf:first N9136f5f0eba24d15b931d0c2fb4d3e78
38 rdf:rest rdf:nil
39 N810f045928974e91ae1734ff17ed17cc rdf:first Na8f416bcdeca47f68b101bf8fb5b4904
40 rdf:rest N52b53f27513644a7a5c0e7aef416eee5
41 N9136f5f0eba24d15b931d0c2fb4d3e78 schema:name Stephanie K. Roessler
42 rdf:type schema:Person
43 Na8f416bcdeca47f68b101bf8fb5b4904 schema:name Xin Wei Wang
44 rdf:type schema:Person
45 anzsrc-for:2620 schema:inDefinedTermSet anzsrc-for:
46 rdf:type schema:DefinedTerm
47 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
48 rdf:type schema:DefinedTerm
49 sg:pub.10.1038/sj.gt.3301923 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043735865
50 https://doi.org/10.1038/sj.gt.3301923
51 rdf:type schema:CreativeWork
52 https://doi.org/10.1159/000072654 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012895947
53 rdf:type schema:CreativeWork
54 https://www.grid.ac/institutes/grid.27235.31 schema:Organization
 




Preview window. Press ESC to close (or click here)


...